Cargando…
The inflammasome and alum-mediated adjuvanticity
Recent reports have implicated the NLRP3-associated inflammasome in the adjuvanticity of alum. Here, we summarize the major findings and ask what this may mean for improving human vaccination.
Autores principales: | Kang, Suk-Jo, Locksley, Richard M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Biology Reports Ltd
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2920669/ https://www.ncbi.nlm.nih.gov/pubmed/20948671 http://dx.doi.org/10.3410/B1-15 |
Ejemplares similares
-
Antigen depot is not required for alum adjuvanticity
por: Hutchison, Sharon, et al.
Publicado: (2012) -
Non-canonical inflammasome activation mediates the adjuvanticity of nanoparticles
por: Muñoz-Wolf, Natalia, et al.
Publicado: (2023) -
Inhibition of elastase enhances the adjuvanticity of alum and promotes anti–SARS-CoV-2 systemic and mucosal immunity
por: Kim, Eunsoo, et al.
Publicado: (2021) -
Nano selenium-enriched probiotic Lactobacillus enhances alum adjuvanticity and promotes antigen-specific systemic and mucosal immunity
por: Liu, Runhang, et al.
Publicado: (2023) -
Effect of alum co-adjuvantation of oil adjuvant vaccine on emulsion stability and immune responses against haemorhagic septicaemia in mice
por: Kumar, Sujeet, et al.
Publicado: (2015)